Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Wilde S, Jetter A, Rietbrock S, Kasel D, Engert A, Josting A, Klimm B, Hempel G, Reif S, Jaehde U, Merkel U, Busse D, Schwab M, Diehl V, Fuhr U.
Wilde S, et al. Among authors: jaehde u.
Clin Pharmacokinet. 2007;46(4):319-33. doi: 10.2165/00003088-200746040-00005.
Clin Pharmacokinet. 2007.
PMID: 17375983
Clinical Trial.